Real-world outcomes associated with vonoprazan-based versus proton pump inhibitor-based therapy for Helicobacter pylori infection in Japan.

Saved in:
Bibliographic Details
Title: Real-world outcomes associated with vonoprazan-based versus proton pump inhibitor-based therapy for Helicobacter pylori infection in Japan.
Authors: Howden CW; University of Tennessee College of Medicine, Memphis, TN 38163, USA., Cook EE; Analysis Group, Inc., Boston, MA, USA., Swallow E; Analysis Group, Inc., Boston, MA, USA., Yang K; Analysis Group, Inc., New York, NY, USA., Guo H; Analysis Group, Inc., Los Angeles, CA, USA., Pelletier C; Phathom Pharmaceuticals, Florham Park, NJ, USA., Jacob R; Phathom Pharmaceuticals, Florham Park, NJ, USA., Sugano K; Jichi Medical University, Shimotsuke, Tochigi, Japan.
Source: Therapeutic advances in gastroenterology [Therap Adv Gastroenterol] 2023 May 02; Vol. 16, pp. 17562848231168714. Date of Electronic Publication: 2023 May 02 (Print Publication: 2023).
Publication Type: Journal Article
Journal Info: Publisher: Sage Publications Country of Publication: England NLM ID: 101478893 Publication Model: eCollection Cited Medium: Print ISSN: 1756-283X (Print) Linking ISSN: 1756283X NLM ISO Abbreviation: Therap Adv Gastroenterol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37153499
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Real-world outcomes associated with vonoprazan-based versus proton pump inhibitor-based therapy for Helicobacter pylori infection in Japan.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Howden+CW%22">Howden CW</searchLink>; University of Tennessee College of Medicine, Memphis, TN 38163, USA.<br /><searchLink fieldCode="AU" term="%22Cook+EE%22">Cook EE</searchLink>; Analysis Group, Inc., Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Swallow+E%22">Swallow E</searchLink>; Analysis Group, Inc., Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Yang+K%22">Yang K</searchLink>; Analysis Group, Inc., New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Guo+H%22">Guo H</searchLink>; Analysis Group, Inc., Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Pelletier+C%22">Pelletier C</searchLink>; Phathom Pharmaceuticals, Florham Park, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Jacob+R%22">Jacob R</searchLink>; Phathom Pharmaceuticals, Florham Park, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Sugano+K%22">Sugano K</searchLink>; Jichi Medical University, Shimotsuke, Tochigi, Japan.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101478893%22">Therapeutic advances in gastroenterology</searchLink> [Therap Adv Gastroenterol] 2023 May 02; Vol. 16, pp. 17562848231168714. <i>Date of Electronic Publication: </i>2023 May 02 (<i>Print Publication: </i>2023).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Sage+Publications%22">Sage Publications </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101478893 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1756-283X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%221756283X%22">1756283X </searchLink><i>NLM ISO Abbreviation: </i>Therap Adv Gastroenterol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37153499
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1177/17562848231168714
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 17562848231168714
    Titles:
      – TitleFull: Real-world outcomes associated with vonoprazan-based versus proton pump inhibitor-based therapy for Helicobacter pylori infection in Japan.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Howden CW
      – PersonEntity:
          Name:
            NameFull: Cook EE
      – PersonEntity:
          Name:
            NameFull: Swallow E
      – PersonEntity:
          Name:
            NameFull: Yang K
      – PersonEntity:
          Name:
            NameFull: Guo H
      – PersonEntity:
          Name:
            NameFull: Pelletier C
      – PersonEntity:
          Name:
            NameFull: Jacob R
      – PersonEntity:
          Name:
            NameFull: Sugano K
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 05
              Text: 2023 May 02
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-print
              Value: 1756-283X
          Numbering:
            – Type: volume
              Value: 16
          Titles:
            – TitleFull: Therapeutic advances in gastroenterology
              Type: main
ResultId 1